Disorders of social functioning and quality of life in patients with gastroesophageal reflux disease while combined with undifferentiated connective tissue dysplasia





social functioning, quality of life, undifferentiated connective tissue dysplasia, Gastroesophageal reflux disease


Introduction. It has been scientifically confirmed that the risk of developing gastroesophageal reflux disease (GERD) increases especially with generalized or regional disruption of connective tissue structure, which is widespread among the population. Patients with such comorbid pathology may have a wide range of symptoms that may go beyond the general symptoms of heartburn and regurgitation. The symptoms and complications of GERD affect general health, daily and social functioning, physical and emotional activity. It also affects the quality of life (QoL) associated with health through frequent breaks during sleep, work and social activities.

Purpose. study the dynamics of the level of quality of life and social functioning in patients with gastroesophageal reflux disease in combination with the syndrome of undifferentiated connective tissue dysplasia.

Methodology. A total of 120 patients were included in the study: 65 men and 55 women: in 75 of them (Group II) GERD occurred on the background of UCTD, in 45 (Group I) as an independent disease. The control group consisted of 12 healthy individuals. The study was comprehensive. The Medical Outcomes Study 36-Item Short-Form Health Status (SF-36),the Gastrointestinal Symptom Rating Scale (GSRS) and the scale of "Personal and social performance" (PSP) -  were used to study patients in detail.

Results and Discussion. Analyzing the results obtained on the basis of the GSRS questionnaire (Table 1), in patients with GERD on the background of UCTD, compared with patients of group I and the control group, there is a significant increase in three and four from the five scales. QoL in patients of Group II on the scale "Abdominal pain" were 14.3 ± 0.4 points, in Group I - 5.6 ± 1.3 points, in the Control Group - 2.4 ± 0.8 points, on the scale "Reflux syndrome": 13.7 ± 0.9, 10.5 ± 1.3 and 3.1 ± 0.9, respectively. "Dyspeptic syndrome" - 15.3 ± 0.4 points in Group II, 12.2 ± 0.6- in Group I and 6.1 ± 0.3- in the control group. "Constipation syndrome" 9.5 ± 0.8, 5.6 ± 1.03 and 5.7 ± 0.4, respectively (p <0,05).

Conclusions: In this research we investigated the effect of comorbid pathology on QoL in patients with GERD, which developed against the background of UCTD. The results confirm that patients with such combined pathology have a lower level of quality of life and social functioning, and the tactics of treatment of such patients should take into account these changes


Denaxas K., Ladas S. D., Karamanolis G. P.(2018). Evaluation and management of esophageal manifestations in systemic sclerosis. Ann Gastroenterol. 31(2):165-170. doi:10.20524/aog.2018.0228.
Dimenäs, E., Carlsson, G., Glise, H., Israelsson, B., & Wiklund, I. (1996). Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scandinavian Journal of Gastroenterology, 31(sup221), 8-13.
Iudici, M., Irace, R., Riccardi, A., Cuomo, G., Vettori, S., & Valentini, G. (2017). Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases. Patient related outcome measures, 8, 7.
Kulich, K. R., Madisch, A., Pacini, F., Piqué, J. M., Regula, J., Van Rensburg, C. J., Ujszászy, L., Carlsson, J., Halling, K., & Wiklund, I. K. (2008). Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health and quality of life outcomes, 6, 12. https://doi.org/10.1186/1477-7525-6-12
Kumar, A., Raja, K., Kumar, S., Quasimuddin, N. & Rizwan, A. (2020). Quality of Life in Gastroesophageal Reflux Disease Three Months After Laparoscopic Nissen’s Fundoplication. Cureus. Cureus. doi:10.7759/cureus.10674
Moskalenko V. F., Bulakh I. Ye., Puzanova O. H. (2014). Metodolohiia dokazovoi medytsyny: pidruchnyk . Kyiv: «Medytsyna», 200 s.
Romash, I. B., & Mishchuk, V. G. (2020). The frequency of visceral and phenotypic markers in patients with the combination of undifferentiated connective tissue disease and gastroesophageal reflux disease. Wiadomo?ci Lekarskie, 73(7), 1492-1498.
Romash I.R., Vynnyk M.I. (2019) Dynamics of Quality of Life Indices in Case of Metabolic Syndrome in Patients with Paranoid Schizophrenia on the Background of Atypical Neuroleptic Agents Application and Improvement of Comorbidity. Ukrains’kyi visnyk psykhonevrolohii. 27,4 (101):62-67. DOI: https://doi.org/10.36927/2079-0325-V27-is4-2019-11




How to Cite

Romash, I. . (2020). Disorders of social functioning and quality of life in patients with gastroesophageal reflux disease while combined with undifferentiated connective tissue dysplasia. Mental Health: Global Challenges Journal, 3(1), 11–16. https://doi.org/10.32437/mhgcj.v3i1.100